MedTrace Logo

MAnagement of METastatic Disease in Campania (MAMETIC)

NCT04595032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3234

Last updated 2024-11-07

No results posted yet for this study

Summary

The MAMETIC Trial represents the first regional epidemiological study that aims to evaluate patients living in Campania with metastatic cancer, with the intent to detect different prevalence of tumors in the metastatic phase and evaluate the local response to the patient's request for assistance.

Condition or disease: Metastatic disease Intervention/treatment: Radiation Treatment

Conditions

Interventions

DEVICE

3DCRT, IMRT, VMAT, SBRT

Radiation treatment

Sponsors & Collaborators

  • National Cancer Institute, Naples

    lead OTHER

Principal Investigators

  • Paolo Muto, MD · National Cancer Institute of Naples

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-11
Primary Completion
2024-02-08
Completion
2024-02-08

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04595032 on ClinicalTrials.gov